최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.32 no.3, 2018년, pp.119 - 130
장석주 (동국대학교 한의과대학 소아과교실) , 김장현 (동국대학교 한의과대학 소아과교실) , 민상연 (동국대학교 한의과대학 소아과교실)
Objectives The purpose of this study is to review the effectiveness of acupuncture treatment in irritable bowel syndrome (IBS). Methods We reviewed 8 randomized controlled trials (RCT) of acupuncture treatment in IBS which were published from 2008 to 2018 in PubMed. The acupoints, methods of assessm...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
IBS는 Rome Ⅱ의 기준에서 어떻게 분류되는가? | IBS는 Rome Ⅱ의 기준에서 배변 양상에 따라 IBS-C, IBS-D, 변비-설사 교대형 (mixed diarrhea and constipation IBS, IBS-M), 미분류 (unsubtyped IBS, IBS-U)로 분류된다. Longstreth 등18)의 연구에 따르면, IBS-C, IBS-D, IBS-M이 전체 환자의 33%를 차지하며, 75%의 환자들이 1년 사이에 진단이 IBS-C와 IBS-D로 서로 변경된다고 하였다. | |
과민성장증후군이란 무엇인가? | 과민성장증후군 (Irritable bowel syndrome, IBS)은 기능적 소화기계 병증으로 기질적인 이상 없이 만성적 재발성 복통, 복부 불편감, 복부 팽만과 변비, 설사 혹은 변비와 설사의 반복 등을 호소하는 질환이다. 사춘기에 흔히 나타나며, 복통은 배변으로 소실되는 경우가 많으나, 급박변, 참기 어려운 배변 등의 비정상적 배변 행위와 대변의 경도와 같은 불규칙한 배변 형태가 발생하기도 한다1). | |
IBS에 대한 기존 치료에 한계는 무엇인가? | IBS에 관한 기존의 일반적인 치료는 심리적인 안정감 및 스트레스 해소를 위하여, 규칙적인 생활습관을 지키고, 심한 경우 신경안정제를 투약하며, 자극적인 음식을 피하고, 장운동이 활발한 경우 진경제, 장기간의 변비인 경우 효과적인 완화제를 사용하는 것이다. 그러나 2001년 발표된 체계적 문헌 고찰에서 기존 약물치료가 충분한 효과를 발휘하지 못한다고 밝혔으며4) 어떤 진경제나 항우울제도 IBS의 모든 증상을 조절하지 못하는 것으로 보고하였다5). 이는 IBS에 대한 기존 치료에 한계가 있음을 의미한다. |
Kim KB, Kim DG, Kim YH, Kim JH, Min SY, Park EJ, Baek JH, Sung HK, Yu SA, Lee SY, Lee JY, Lee HJ, Chang GT, Jeong MJ, Chai JW, Cheon JH, Han YJ, Han JK. Hanbangsoacheongsonyeonuihak (sang). Seoul: Ui Sung Dang Publishing Co. 2015:402.
Park DW, Lee OY, Shim SG, Jun DW, Lee KN, Kim HY, Lee HL Yoon BC, Choi HS. The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III. J Neurogastroenterol Motil. 2010;16(2):186-93.
Park JH, Byeon JS, Shin WG, Yoon YH, Cheon JH, Lee KJ, Park HJ. Diagnosis of irritable bowel syndrome: a systematic review. Korean J Gastroenterol. 2010;55(5): 308-15.
Akehurst R, Kaltenthaler E. Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 2001;48(2):272-82.
Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2005;18(2):CD003460.
Chao GQ, Zhang S. Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2014;20(7):1871-7.
Won TH, Moon SJ, Moon G. A study on the oriental recognition of irritable bowel syndrome: centering around the etiological factors pathological mechanism and diagnosis and treatment. Korean J Med. 1993;14(1): 196-206.
Stuardi T, MacPherson H. Acupuncture for irritable bowel syndrome: diagnosis and treatment of patients in a pragmatic trial. J Altern Complement Med. 2012; 18(11):1021-7.
Lowe C, Aiken A, Day AG, Depew W, Vanner SJ. Sham acupuncture is as efficacious as true acupuncture for the treatment of IBS: a randomized placebo controlled trial. Neurogastroenterol Motil. 2017;29(7):e13040.
Zheng H, Li Y, Zhang W, Zeng F, Zhou SY, Zheng HB, Zhu WZ, Jing XH, Rong PJ, Tang CZ, Wang FC, Liu ZB, Wang SJ, Zhou MQ, Liu ZS, Zhu B. Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: a randomized controlled trial. Medicine (Baltimore). 2016;95(24):e3884.
Zhenzhong L, Xiaojun Y, Weijun T, Yuehua C, Jie S, Jimeng Z, Anqi W, Chunhui B, Yin S. Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome. J Tradit Chin Med. 2015;35(4):402-10.
Zhao JM, Lu JH, Yin XJ, Chen XK, Chen YH, Tang WJ, Jin XM, Wu LY, Bao CH, Wu HG, Shi Y. Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial. Chin J Integr Med. 2015;21(11):855-65.
MacPherson H, Tilbrook H, Bland JM, Bloor K, Brabyn S, Cox H, Kang'ombe AR, Man MS, Stuardi T, Torgerson D, Watt I, Whorwell P. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterol. 2012;12:150.
MacPherson H, Tilbrook H, Agbedjro D, Buckley H, Hewitt C, Frost C. Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomised controlled trial. Acupunct Med. 2017;35(1):17-23.
Sun JH, Wu XL, Xia C, Xu LZ, Pei LX, Li H, Han GY. Clinical evaluation of soothing Gan and invigorating Pi acupuncture treatment on diarrhea-predominant irritable bowel syndrome. Chin J Integr Med. 2011;17(10): 780-5.
Anastasi JK, McMahon DJ, Kim GH. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion. Gastroenterol Nurs. 2009;32(4):243-55.
Lembo AJ, Conboy L, Kelley JM, Schnyer RS, McManus CA, Quilty MT, Kerr CE, Drossman D, Jacobson EE, Davis RB. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol. 2009;104(6):1489-97.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-91.
Wasserstein RL, Lazar NA. The ASA’s statement on p-values: context, process, and purpose. Am Stat. 2016; 70(2):129-33.
Korean Acupuncture & Moxibustion Medicine Society. The acupuncture and moxibustion medicine. Seoul: Jipmoondang. 2016.
Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128(3):264-71.
Jadad AR, Moore RA, Caroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clin Trials. 1996;17(1):1-12.
Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med. 1999;107(5 Suppl 1):S91-7.
Lim B, Manheimer E, Lao L, Ziea E, Wisniewski J, Liu J, Berman B. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006; 18(4):CD005111.
Dong WZ, Zou DW, Li ZS, Zou XP, Zhu AY, Xu GM, Yin N, Gong YF, Sun ZX, Man XH. Study of visceral hypersensitivity in irritable bowel syndrome. Chin J Dig Dis. 2004;5(3):103-9.
Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004; 141(8):1285-93.
Silverman DH, Munakara JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112(1):64-72.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.